How much funding has Expansion Therapeutics raised?

Expansion Therapeutics has raised $55.3M in total funding, most recently a Series B round.

Who are Expansion Therapeutics's investors?

Expansion Therapeutics's investors include Cormorant Asset Management, 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, Sanofi Ventures, RA Capital Management.

When was Expansion Therapeutics founded?

Expansion Therapeutics was founded in 2018.

Where is Expansion Therapeutics headquartered?

Expansion Therapeutics is headquartered in Jupiter, Florida, United States.

What industry is Expansion Therapeutics in?

Expansion Therapeutics operates in Biotech, Healthcare.

How many employees does Expansion Therapeutics have?

Expansion Therapeutics has 11-50 employees.

Expansion Therapeutics

Small molecule medicines for RNA-mediated diseases

Jupiter, United States · Founded 2018 · $55.3M raised

Biotech

Healthcare

Headquarters: Jupiter, Florida
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: expansionrx.com
Total Funding: $55.3M
Last Round: Series BSep 2021
Rounds: 2

About

Expansion Therapeutics is a clinical-stage biotechnology company focused on developing small molecule therapies for RNA-mediated diseases, particularly repeat expansion disorders such as myotonic dystrophy. The company was co-founded by Matthew Disney and Kevin Forrest and launched with $55.3 million in Series A financing from 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures.

Summary

Expansion Therapeutics is a Biotech company based in Jupiter, United States, founded in 2018. It has raised $55.3M in total across 2 rounds, most recently a Series B round in Sep 2021. Investors include Cormorant Asset Management, 5AM Ventures and Kleiner Perkins.